Sagimet Biosciences Inc.
SGMT
$10.55
$1.2713.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -47.08M | -43.51M | -51.04M | -57.67M | -59.38M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.51M | 7.20M | 6.44M | 5.93M | 4.96M |
| Change in Net Operating Assets | -4.15M | -3.42M | -1.05M | 6.90M | 195.00K |
| Cash from Operations | -41.72M | -39.73M | -45.65M | -44.84M | -54.23M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 629.00K | 11.36M | 4.56M | 48.00K | 597.00K |
| Cash from Investing | 629.00K | 11.36M | 4.56M | 48.00K | 597.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 175.46M | 275.00K | 275.00K | 275.00K | 1.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.80M | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 164.66M | 275.00K | 275.00K | 275.00K | 1.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.57M | -28.09M | -40.82M | -44.52M | -53.63M |